A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer.

Chenxue Jiang,Shuiyun Han,Wucheng Chen,Xiaozhen Ying,He Wu,Yaoyao Zhu,Guodong Shi,Xiaojiang Sun,Yaping Xu

Oncotarget（2018）

引用 5|浏览7

暂无评分

摘要

Shrinking field radiotherapy during chemoradiotherapy in stage III non-small cell lung cancer seems safe with acceptable toxicities and relapse, and potentially spares normal tissues and enables dose escalation. Prospective trials are warranted.

查看译文

关键词

adaptive radiotherapy,chemoradiation therapy,dose escalation,lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要